{"entity":{"type":"insider","cik":"0001724190","url":"/insider/0001724190","json_url":"/insider/0001724190.json","name":"Quinn William P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":9,"first":"2018-12-12","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Quinn William P.","source":"filing","n_filings":9,"first_seen":"2018-12-12","last_seen":"2026-02-04"}],"transactions":[{"id":6228571,"accession":"0001193125-26-037697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-037697","line_url":"/filing/0001193125-26-037697#line-1","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Director, Officer (President, CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125.0,"shares_display":"125","price_per_share":4.607,"price_display":"4.61","price_state":"stated","total_value":575.875,"total_display":"575.88","total_whole":"576","shares_owned_after":2313.0,"shares_owned_after_display":"2,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2026-02-04","scope":"insider"},{"id":5069452,"accession":"0001193125-25-250332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-250332","line_url":"/filing/0001193125-25-250332#line-1","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Director, Officer (President, CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125.0,"shares_display":"125","price_per_share":5.492,"price_display":"5.49","price_state":"stated","total_value":686.5,"total_display":"686.50","total_whole":"687","shares_owned_after":2188.0,"shares_owned_after_display":"2,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-06","filed_date":"2025-10-24","scope":"insider"},{"id":4496038,"accession":"0000950170-25-063840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-063840","line_url":"/filing/0000950170-25-063840#line-2","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Director, Officer (President, CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.4965,"price_display":"0.50","price_state":"stated","total_value":1241.25,"total_display":"1,241.25","total_whole":"1,241","shares_owned_after":41272.0,"shares_owned_after_display":"41,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2025-05-05","scope":"insider"},{"id":4496035,"accession":"0000950170-25-063840","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-063840","line_url":"/filing/0000950170-25-063840#line-1","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Director, Officer (President, CEO and CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.6374,"price_display":"0.64","price_state":"stated","total_value":1593.5,"total_display":"1,593.50","total_whole":"1,594","shares_owned_after":38772.0,"shares_owned_after_display":"38,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-06","filed_date":"2025-05-05","scope":"insider"},{"id":7955596,"accession":"0001209191-23-058458","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-058458","line_url":"/filing/0001209191-23-058458#line-3","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":7125.0,"total_display":"7,125.00","total_whole":"7,125","shares_owned_after":36272.0,"shares_owned_after_display":"36,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-13","scope":"insider"},{"id":7955593,"accession":"0001209191-23-058458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-058458","line_url":"/filing/0001209191-23-058458#line-2","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.782,"price_display":"0.78","price_state":"stated","total_value":1955.0,"total_display":"1,955.00","total_whole":"1,955","shares_owned_after":28772.0,"shares_owned_after_display":"28,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-13","scope":"insider"},{"id":7955588,"accession":"0001209191-23-058458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058458","line_url":"/filing/0001209191-23-058458#line-1","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1829.0,"shares_display":"1,829","price_per_share":1.1815,"price_display":"1.18","price_state":"stated","total_value":2160.9635,"total_display":"2,160.96","total_whole":"2,161","shares_owned_after":26272.0,"shares_owned_after_display":"26,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-12-13","scope":"insider"},{"id":7896153,"accession":"0001209191-23-007567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-007567","line_url":"/filing/0001209191-23-007567#line-2","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1789.0,"shares_display":"1,789","price_per_share":1.1815,"price_display":"1.18","price_state":"stated","total_value":2113.7035,"total_display":"2,113.70","total_whole":"2,114","shares_owned_after":24443.0,"shares_owned_after_display":"24,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2023-02-07","scope":"insider"},{"id":7896149,"accession":"0001209191-23-007567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007567","line_url":"/filing/0001209191-23-007567#line-1","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.6405,"price_display":"1.64","price_state":"stated","total_value":4101.25,"total_display":"4,101.25","total_whole":"4,101","shares_owned_after":22654.0,"shares_owned_after_display":"22,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2023-02-07","scope":"insider"},{"id":4827045,"accession":"0000899243-21-047518","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-047518","line_url":"/filing/0000899243-21-047518#line-3","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.715,"price_display":"4.72","price_state":"stated","total_value":23575.0,"total_display":"23,575.00","total_whole":"23,575","shares_owned_after":20154.0,"shares_owned_after_display":"20,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-09","scope":"insider"},{"id":4827039,"accession":"0000899243-21-047518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-047518","line_url":"/filing/0000899243-21-047518#line-2","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35.0,"shares_display":"35","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":162.4,"total_display":"162.40","total_whole":"162","shares_owned_after":15154.0,"shares_owned_after_display":"15,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-09","scope":"insider"},{"id":4827030,"accession":"0000899243-21-047518","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-047518","line_url":"/filing/0000899243-21-047518#line-1","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1221.0,"shares_display":"1,221","price_per_share":16.65,"price_display":"16.65","price_state":"stated","total_value":20329.65,"total_display":"20,329.65","total_whole":"20,330","shares_owned_after":15119.0,"shares_owned_after_display":"15,119","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-12-09","scope":"insider"},{"id":4773184,"accession":"0001209191-21-008741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-008741","line_url":"/filing/0001209191-21-008741#line-1","is_derivative":false,"issuer_cik":"0001641281","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001641281","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":24000.0,"total_display":"24,000.00","total_whole":"24,000","shares_owned_after":13898.0,"shares_owned_after_display":"13,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":2375582,"accession":"0000899243-20-009976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-009976","line_url":"/filing/0000899243-20-009976#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.3655,"price_display":"0.37","price_state":"stated","total_value":2193.0,"total_display":"2,193.00","total_whole":"2,193","shares_owned_after":127697.0,"shares_owned_after_display":"127,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-29","filed_date":"2020-04-02","scope":"insider"},{"id":2375579,"accession":"0000899243-20-009976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-009976","line_url":"/filing/0000899243-20-009976#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.6461,"price_display":"0.65","price_state":"stated","total_value":3876.6,"total_display":"3,876.60","total_whole":"3,877","shares_owned_after":121697.0,"shares_owned_after_display":"121,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2020-04-02","scope":"insider"},{"id":6513638,"accession":"0001179110-18-013757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-013757","line_url":"/filing/0001179110-18-013757#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001724190","owner_name":"Quinn William P.","owner_display_name":"Quinn William P.","owner_url":"/insider/0001724190","role":"Officer (CFO,Sr.V.P. Finance, Corp.Dev)","role_mark":"O","role_mark_label":"Officer (CFO,Sr.V.P. Finance, Corp.Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO,Sr.V.P. Finance, Corp.Dev.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":18800.0,"total_display":"18,800.00","total_whole":"18,800","shares_owned_after":52000.0,"shares_owned_after_display":"52,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641281","name":"Bolt Biotherapeutics, Inc.","url":"/issuer/0001641281","role":"Director, Officer (President, CEO and CFO)","n_filings":7,"first_seen":"2021-02-09","last_seen":"2026-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"SUNESIS PHARMACEUTICALS INC","url":"/issuer/0001061027","role":"Officer","n_filings":2,"first_seen":"2018-12-12","last_seen":"2020-04-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001724190","retrieved_at":"2026-08-26T13:06:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}